Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shawn Boomsma

Orthopaedic Trauma Miami, FL Doctor of Osteopathy

NPI 1407296486 CMS profile 2784048

1800 Nw 10Th Ave Ste T-215, Miami, FL 33136

Open in the dashboard

General payments

$16,658

373 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shawn Boomsma of Miami, FL is reported in the CMS Open Payments database as having received $16,658 across 373 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 64th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,915 98
2024 General $2,849 88
2023 General $3,990 98
2022 General $1,899 39
2021 General $985 24
2020 General $1,068 18
2019 General $1,952 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shawn Boomsma
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Shawn Boomsma were reported at $3,915. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Shawn Boomsma Orthopaedic Trauma median Middle half National median
2019 $1,952 $1,475 $264–$6,401 $163
2020 $1,068 $596 $120–$4,020 $114
2021 $985 $919 $171–$4,697 $132
2022 $1,899 $1,547 $272–$7,240 $149
2023 $3,990 $1,330 $247–$5,875 $160
2024 $2,849 $1,288 $277–$6,797 $164
2025 $3,915 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $12,896 339 payments
  2. Synthes GmbH $1,125 1 payment
  3. Smith+Nephew, Inc. $1,092 17 payments
  4. Southern Edge Orthopaedics, Inc. $541 1 payment
  5. Medical Device Business Services, Inc. $335 4 payments
  6. DePuy Synthes Sales Inc. $307 6 payments
  7. Aroa Biosurgery Incorporated $250 3 payments
  8. Acumed LLC $114 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $13,826 366 payments
  2. Travel and Lodging $1,631 2 payments
  3. Education $1,201 5 payments
Products named General payments · program years 2019–2025
  1. T2 Trauma & Extremeties $1,687 35 payments
  2. T2 ALPHA $1,658 56 payments
  3. VARIAX $1,435 46 payments
  4. PANGEA $1,405 23 payments
  5. HOFFMANN $1,307 34 payments
  6. AXSOS $802 17 payments
  7. GAMMA $658 18 payments
  8. HYDROSET $520 14 payments
  9. N/A $450 9 payments
  10. T2 Nails $423 15 payments
  11. Other $4,317 97 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 17 billing codes

Paid by Medicare

$18,481

Medicare's payments for the services billed

Medicare patients

16

Average age 77

Services billed

27

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

373 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record